News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Piramal Healthcare Limited in Talks to Buy US Contract Drug Maker Cambridge Major Laboratories, Inc. for $200 Million



6/19/2012 7:37:16 AM

Piramal Healthcare (PHL) is in talks to buy US contract drug manufacturer Cambridge Major Laboratories (CML) for around $200 million, a person with direct knowledge of the development said. “Early stage negotiations are on and it will take a while to conclude the deal,” he said. PHL is the flagship company of the Ajay Piramal-owned Piramal Group while the Wisconsin-based unlisted CML makes pharmaceutical intermediates and active pharmaceutical ingredients (APIs) used in drugs. The company is a global chemistry outsourcing partner to pharmaceutical and biotechnology companies, owning three facilities in US and one in Europe.

Read at Financial Express
Read at Money Control
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES